Cargando…
TRIM11 promotes breast cancer cell proliferation by stabilizing estrogen receptor α
Breast cancer is the most commonly diagnosed malignancy in female worldwide, over 70% of which are estrogen receptor α (ERα) positive. ERα has a crucial role in the initiation and progression of breast cancer and is an indicator of endocrine therapy, while endocrine resistance is an urgent problem i...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Neoplasia Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326724/ https://www.ncbi.nlm.nih.gov/pubmed/32599554 http://dx.doi.org/10.1016/j.neo.2020.06.003 |